Bruce Booth

Venture Capital, Angel/Individual

Bruce Booth is a venture capital investor and angel investor. They invest in Healthcare Delivery, Wellness, Biotechnology and Consumer Health, typically at the Seed stage. Their portfolio includes Nimbus Therapeutics, Magenta Therapeutics, Bicycle Therapeutics and Miragen Therapeutics and 13 other companies.

Investment stages

Industries

Portfolio companies (17)

Similar investors in Healthcare Delivery

  • Ben Trumbull

    Venture Capital, Private Equity Firm, Micro VC · United States

    SeedPre-SeedHealth CareHealthcare DeliveryCybersecurityWellness

    Portfolio: Aptible, Vantage Point Logistics

    Contact details available

  • Connor DavidsonVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedPre-SeedHealth CareHealthcare DeliveryPaymentsCybersecurity

    Contact details available

  • Armando Badillo M.

    Venture Capital, Private Equity Firm, Angel/Individual · Spain

    SeedPre-SeedHealth CareHealthcare DeliveryEducationClean Technology

    Contact details available

  • Janelle Goulard

    Venture Capital, Private Equity Firm · United States

    Series AHealth CareTelecommunicationsHealthcare DeliveryHuman Computer Interaction

    Portfolio: Modulim, Sun Genomics

    Contact details available

  • Hugh Chow

    Venture Capital, Angel/Individual · United States

    SeedPre-SeedHealthcare DeliveryArtificial Intelligence (AI)Clean TechnologyHealth and Hospital Services

    Contact details available

  • Rex RhewVerified

    Angel/Individual · United States

    SeedPre-SeedAdvertisingHealthcare DeliveryData ServicesClean Technology

    Contact details available

  • Rich Maloy

    Venture Capital, Private Equity Firm, Micro VC · United States

    SeedPre-SeedAdvertisingHealth CareAutonomous VehiclesE-commerce

    Portfolio: FloatMe, TrueCoach

    Contact details available

  • David GrayzelVerified

    Venture Capital · United States

    SeedHealth CareHealthcare DeliveryWomen FoundedLife Science

    Portfolio: Delinia, Xilio Therapeutics

    Contact details available